Aurigene Oncology CEO On Biotech Valuations, CAR-Ts And Reimbursement Models

 
• By Anju Ghangurde
  
Dr Murali Ramachandra, CEO of Aurigene Oncology
Dr Murali Ramachandra, CEO, Aurigene Oncology (Aurigene)

More from Interviews

More from India